A Trial to Evaluate the Effect of the Proton Pump Inhibitor Esomeprazole on the Single-dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 27, 2019

Primary Completion Date

April 15, 2019

Study Completion Date

April 15, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

TAK-906

TAK-906 capsules.

DRUG

Esomeprazole

Esomeprazole capsules.

Trial Locations (1)

85283

Celerion, Tempe

All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY